Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor - PubMed (original) (raw)

Comparative Study

Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor

V J Quagliarello et al. J Clin Invest. 1991 Apr.

Abstract

The diversity of infectious agents capable of inducing meningitis and blood-brain barrier (BBB) injury suggests the potential for a common host mediator. The inflammatory polypeptides, IL-1 and TNF, were tested in an experimental rat model as candidate mediators for induction of meningitis and BBB injury. Intracisternal challenge of rIL-1 beta into rats induced neutrophil emigration into cerebrospinal fluid (CSF) and significantly increased BBB permeability to systemically administered 125I-BSA as early as 3 h later (P less than 0.05). This injury was reversible, dose dependent and significantly inhibited by prior induction of systemic neutropenia (via intraperitoneal cyclophosphamide) or preincubation of the rIL-1 beta inoculum (50 U) with an IgG monoclonal antibody to rIL-1 beta. Similar kinetics and reversibility of CSF inflammation and BSA permeability were observed using equivalent dose inocula of rIL-1 alpha. rTNF-alpha was less effective as an independent inducer of meningitis or BBB injury over an inoculum range of 10(1) U (0.0016 micrograms/kg)-10(6) U (160 micrograms/kg) when injected intracisternally, but inoculum combinations of low concentrations of rTNF alpha (10(3) U) and rIL-1 beta (0.0005-5.0 U) were synergistic in inducing both meningitis and BBB permeability to systemic 125I-BSA. These data suggest that in situ generation of interleukin-1 within CSF (with or without TNF) is capable of mediating both meningeal inflammation and BBB injury seen in various central nervous system infections.

PubMed Disclaimer

Cited by

Interleukin-1β accelerates the onset of stroke in stroke-prone spontaneously hypertensive rats.
Chiba T, Itoh T, Tabuchi M, Nakazawa T, Satou T. Chiba T, et al. Mediators Inflamm. 2012;2012:701976. doi: 10.1155/2012/701976. Epub 2012 Dec 27. Mediators Inflamm. 2012. PMID: 23326018 Free PMC article.
Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment.
Reale M, Costantini E, Greig NH. Reale M, et al. Front Psychiatry. 2021 Mar 5;12:536257. doi: 10.3389/fpsyt.2021.536257. eCollection 2021. Front Psychiatry. 2021. PMID: 33746786 Free PMC article. Review.
The role of cytokines and inflammatory cells in perinatal brain injury.
McAdams RM, Juul SE. McAdams RM, et al. Neurol Res Int. 2012;2012:561494. doi: 10.1155/2012/561494. Epub 2012 Mar 11. Neurol Res Int. 2012. PMID: 22530124 Free PMC article.
Differential effect of p47phox and gp91phox deficiency on the course of Pneumococcal Meningitis.
Schaper M, Leib SL, Meli DN, Brandes RP, Täuber MG, Christen S. Schaper M, et al. Infect Immun. 2003 Jul;71(7):4087-92. doi: 10.1128/IAI.71.7.4087-4092.2003. Infect Immun. 2003. PMID: 12819099 Free PMC article.
Involvement of tumor necrosis factor alpha and interleukin-1beta in enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae.
Yuhas Y, Shulman L, Weizman A, Kaminsky E, Vanichkin A, Ashkenazi S. Yuhas Y, et al. Infect Immun. 1999 Mar;67(3):1455-60. doi: 10.1128/IAI.67.3.1455-1460.1999. Infect Immun. 1999. PMID: 10024595 Free PMC article.

References

1. J Cell Biol. 1967 Jul;34(1):207-17 - PubMed
1. J Exp Med. 1990 Aug 1;172(2):497-507 - PubMed
1. N Engl J Med. 1984 Oct 4;311(14):912-4 - PubMed
1. Infect Immun. 1984 Oct;46(1):81-6 - PubMed
1. J Infect Dis. 1985 May;151(5):859-68 - PubMed

Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor - PubMed (original) (raw)